Early exponential phase USA300 strains UAMS1378 or LAC (2 x 10 7 /ml) were cultured as above with either broth, 100 nM AIP1, or AIP1 with 2 µg/ml VLDL for 1 hr. For strain LAC, the VLDL was pre-incubated with either IgG1 anti-apoB (mAb C1.4) or isotype control (both 5 µg/ml) on ice for 30 min prior to addition to the assay. In addition, LAC was incubated with either 10% PHS treated with murine IgG1 or with 10% PHS treated with mAb C1.4 anti-apoB and cultured as indicated in the figure legends. RNAIII was quantified relative to 16S RNA using a probebased assay as described with minor modifications (Sawires and Gresham, 2008). RNA was isolated and purified using the Qiagen RNAprotect Bacteria Reagent and RNeasy Mini Kit (Qiagen, Valencia, CA). Contaminating DNA was removed by an on-column DNase treatment.
control, no RNAIII was detected in the agr deletion mutant RN6911. Cycling conditions were 2 minutes at 50°C, 10 minutes at 95°C, and 40 cycles of 15 seconds at 95°C with 1 minute at 60°C.
The primer-probe sequences used were as follows: rnaIII forward primer 5'-AATTAGCAAGTGAGTAACATTTGCTAGT-3', rnaIII probe 5'-6-FAMAGTTAGTTTCCTTGGACTCAGTGCTATGTATTTTTCTT-BHQ-2-3', rnaIII reverse primer 5'-GATGTTGTTTACGATAGCTTACATGC-3', 16S forward primer 5'-TGATCCTGGCTCAGGATGA-3', 16S probe 5'-6-FAMCGCTGGCGGCGTGCCTA-BHQ-2-3', 16S reverse primer 5'TTCGCTCGACTTGCATGTA-3'.
Virulence Factor Assays
Lipase and alpha hemolysin were measured in 0.45 µm filtered cultured supernatants from bacterial strains grown as above in TSB with and without the relevant AIP or AIP treated with various antagonists. Lipase (7 hr of culture) was measured as described using a triglyceride substrate, tributyrin (Smeltzer et al., 1992) . Alpha hemolysin (6.5 hr of culture) was measured as described using rabbit erythrocyte lysis (Bernheimer, 1988) . One unit of hemolytic activity was defined as the amount of bacterial supernatant able to liberate half of the total hemoglobin from the erythrocytes.
AIP Binding Assay
Early-exponential phase S. aureus (RN 6390 or LAC at 2 x 10 7 cfu/ml) were incubated in 1 ml TSB in polystyrene tubes with shaking for 3 hours at 37°C. Cultures were incubated in the presence of 1 µM FITC-AIP1 or control FITC-IgG alone or in combination with 2 µg/ml VLDL, 10 µg/ml apoB, 10 µg/ml apoA1, or 1 µM native AIP1. PBS was used as a vehicle control.
Following incubation, samples were washed and then fixed in 1% paraformaldehyde/25 mM CaCl 2 . Binding of FITC-AIP1 to the bacteria was determined by flow cytometry.
Surface Plasmon Resonance
Surface plasmon resonance was performed with the Biacore X100 (Biacore Life Sciences, GE Healthcare) to analyze the interaction of apoproteins with immobilized AIP1. N-terminal biotinylated AIP1 in both the native and linear conformation were immobilized on streptavidin sensor chips according to the manufacturer's protocol. The chips were regenerated with 50 mM NaOH, 1 M NaCl and then washed with immobilization buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 3 mM EDTA). The biotinylated AIPs were pulsed onto the chip at 30 µg/ml for 420 s at a flow rate of 10 µl/min followed by extensive washing. For binding studies, the analytes (apoB, apoA1, and apoC1) at 10 nM in running buffer (10 mM Hepes, pH 7.4, 250 mM NaCl, 3 mM EDTA were applied at a flow rate of 10 µl/min with a contact time of 60 s and a dissociation time of 60 s. Chip platforms could be regenerated to permit additional binding studies after a 60 s wash with 0.5% SDS followed by 120 s stabilization period. For each experiment specific binding was measured as the RU generated by analyte binding to the test surface minus RU generated by analyte binding to the reference surface (streptavidin without biotin-AIP1). Kinetic data for apoB binding to biotin-AIP1 were collected at a flow rate of 30 µl/min with association measured at 60 s and dissociation measured over 300 s. The Biacore evaluation software (X100 Cells (1 x 10 6 ) were incubated in suspension in polystyrene tubes in 1 ml of serum-free, phenol red-free DMEM containing either 1 µg/ml DiI-Ac-LDL plus 9 µg/ml Ac-LDL or 10 µg/ml Ac-LDL at 4°C for 30 minutes. Following incubation, 1 µM FITC-AIP1 or FITC-streptavidin was added, mixed gently, then placed at 37°C for 10 or 30 minutes. For controls, AcLDL was incubated with mAb anti-apoB on ice for 30 min prior to addition to the cells. In addition, 1 µM FITC-AIP1 and 10 µg AcLDL were incubated on ice for 1 hr and then dialyzed prior to addition to the cells. Following treatment, cells were washed twice in buffer, fixed with 3% paraformaldehyde for 10 minutes, rinsed and resuspended in PBS. Cytospins were made using a Shandon Cytospin 3 (Thermo Scientific, Waltham, MA), and coverslipped with Prolong Gold anti-fade. Images were acquired on a Zeiss LSM 510 confocal microscope and the percent colocalization of green and red fluorescence determined using Slidebook software (Intelligent Imaging Innovations, Denver, CO).
Mice
The appropriate institutional committees approved all experiments involving animals. C57BL/6 mice (≈ 10 wk, ≈ 22-28 g) from Charles Rivers (Wilmington, MA), NADPH oxidase knock-out on the C57BL/6 background (gp91 phox -/-) (Pollock et al, 1995, B6 x 129, and PCSK9 knock-out (Pcsk9-/-) (Rashid et al., 2005) on the B6 x 129 background all from Jackson Laboratory (Bar Harbor, ME) were gender-and age-matched. Mice receiving 4APP treatment were injected i.p. 48 hours and 24 hours prior to infection with 100 µl of 5 mg/ml 4APP prepared by dissolving in 1 M HCl at 100 mg/ml and diluted to 5 mg/ml in 0.025 M phosphate buffer (pH 8). The solution was adjusted to pH 4 with 7.5% NaHCO 3 immediately before injection. Total cholesterol levels were determined using a kit (Thermo Electron, Louisville, CO) following the manufacturer's instructions. Wild-type levels were 113 ± 2.5 mg/dl, 4APP treatment reduced levels to 56.5 ± 1.9 mg/dl, and PCSK9 deficiency reduced levels to 84.3 ± 13 mg/dl.
Air Pouch Infection Model
Subcutaneous air pouches were created and infected with early exponential phase bacteria at the dose indicated in the figure legends as previously described (Rothfork et al., 2003; Rothfork et al., 2004) . Twenty-five to 28 hr after infection, the mice were scored for morbidity by the following scale: Appearance: 0-4; natural behavior: 0-3; hydration status (skin pinch test): 0-3; provoked behavior: 0-4. The morbidity score is the sum of the scores in the 4 categories with a maximum of 14 at which point the mice were considered moribund. The following parameters were determined as described (Rothfork et al., 2004) : lavage and spleen CFU, weight loss, in vivo promoter activation of bacteria isolated from the lavage, and cytokine levels in the lavage fluid (MIP-2 ELISA from R&D Systems, Minneapolis, MN).
Tissue Invasion Assay
Basolateral pouch tissue was surgically removed and fixed in 3% paraformaldehye containing 0.1 mM CaCl 2 and 0.1 mM MgCl in PBS for 3 to 4 hours on ice. After rinsing in PBS, they were stored overnight in 25% sucrose in PBS, oriented and embedded in OCT (Sakura Finetek, Torrance, CA) in cryomolds, frozen in liquid nitrogen, and stored at -80°C. Cryosections (10 µm) were cut onto slides and fixed and permeabilized with acetone at -20°C for 5 minutes, rehydrated with PBS, blocked for endogenous biotin with a streptavidin-biotin blocking kit (Vector Labs, Burlingame, CA), and blocked with 5% normal rabbit serum in PBS containing 0.1% Tween and 1% BSA for 2 hr at 4°C. The blocked sections were stained with 2µg/ml mouse IgG3 anti-S. aureus (GeneTex Inc, San Antonio, Tx) labeled with biotin (FluoReporter MiniBiotin-XX, Molecular Probes, Eugene, Or) for 1 hour at 4°C, rinsed and incubated with 0.5 µg/ml streptavidin-rhodamine (Jackson ImmunoResearch, West Grove, PA) for 30 min at 4°C, rinsed, and cover-slipped with ProLong Gold antifade reagent (Molecular Probes, Eugene OR).
Uninfected pouch tissue stained as above served as the negative control. Images were acquired on a Zeiss LSM 510 confocal microscope. Bacterial density as a measure of in vivo biofilm formation in the epidermis and tissue invasion into the dermis was quantified from LSM images using Slidebook software (Intelligent Imaging Innovations, Denver, CO). Regions of interest were selected using histiologic criteria for the epidermis (~first 100 µm) or dermis (~200-300 µm) and the total area and the portion of that area stained for S. aureus quantified in microns 2 .
Values are displayed as % of epidermis or dermis stained from a minimum of 19 sections for each experimental condition. Total bacteria were determined by adding green, yellow and red fluorescence for the relevant sections and quorum-sensing bacteria determined by adding green and yellow fluorescence for the relevant sections. TSB and 10% either pooled human serum (PHS) or 10% lipoprotein deficient pooled human serum (PHS) at 37°C with shaking. To prevent clumping, the samples were sonicated on ice at 30 min intervals. At the indicated times, the bacteria were plated for CFU determination and washed and fixed for flow cytometry to determine GFP induction. Spontaneous agr:P3 promoter activation is significantly enhanced in the presence of LPDS vs PHS after 5 and 7 hrs of culture whereas bacterial CFU is unaffected. Data are represented as the mean ± SEM, n=2 performed in duplicate.
Supplemental References
(B) ALC1743 (non-fluorescent, early exponential phase, 3.5 x 10 7 /ml) were cultured in 90% TSB and 10% PHS (pretreated with either 10 µg/ml murine IgG1 or murine IgG1 anti-apoB N-term mAb C1.4 on ice for 30 min) for 3 hr at 37°C with shaking. To prevent clumping, the samples were sonicated on ice at 30 min intervals. At the indicated times, the bacteria were washed and fixed for flow cytometry to determine GFP induction. Spontaneous agr:P3 promoter activation is significantly enhanced in the presence of anti-apoB treated PHS vs. the isotype control treated PHS after 3 hrs of culture. Data are represented as the mean ± SEM, n=2 performed in duplicate.
(C) USA300 LAC wild-type (early exponential phase, 3.5 x 10 7 /ml) were cultured in 90% TSB and 10% PHS (pretreated with either 10 µg/ml murine IgG1 or murine IgG1 anti-apoB N-term mAb C1.4 on ice for 30 min) for 3 hr at 37°C with shaking. To prevent clumping, the samples were sonicated on ice at 30 min intervals. At the indicated times, RNA was extracted and RNAIII quantified relevant to 16S RNA by qRT-PCR as described in the Materials and Methods. with or without increasing concentrations of purified apoB. After 6.5 hours, promoter activation was measured by flow cytometry. Data are represented as the mean ± SEM, n=3.
(B) Alpha hemolysin in culture supernatants generated by growing bacteria in the presence of 100 nM AIP1 (synthetic or partially purified from culture supernatant by size exclusion) with or without 8 µg/ml apoB for 6.5 hr was measured in a hemolytic assay. SH1000 is a sigma B corrected variant of RN6390, FPR 3757 is a MRSA USA 300 PFGE clinical isolate, and NM 400 is an agr group 3 MRSA USA 400 PFGE clinical isolate. Data are represented as the mean ± SEM, n=3.
(C) Inhibition of spontaneous alpha hemolysin production by two MRSA USA300 strains, UAMS1378 and LAC, after 6.5 hr of culture in the presence and/or absence of purified apoB.
Data are represented as the mean ± SEM, n=2 performed in duplicate.
(D) Lipase in culture supernatants generated by culturing NM300 (MRSA USA 300 clinical isolate) with 100 nM AIP1 with or without apoB (5 µg/ml) for 7 hr was measured by the rate of Mice were treated with 100 µl of 5 mg/ml 4APP or vehicle control (0.025M phosphate buffer) (n=8 for each group) i.p. 48 and 24 hours prior to infection of air pouches with either 2.5 x 10 7 USA300 UAMS1378 or Δagr UAMS1540). At 28 hours hrs post infection, the following parameters were determined and the data represented as the mean ± SEM:
(A) Morbidity score 0-14. 
